Comparing Deep and Superficial Dry Needling for Neck Pain: An Ultrasound and EMG Study
1 other identifier
interventional
44
1 country
1
Brief Summary
The purpose of this clinical trial is to compare the effects of deep versus superficial dry needling (DN) on the ultrasound and electromyographic (EMG) characteristics of myofascial trigger points (MTrPs) in the upper trapezius muscle of patients with neck pain. Researchers aim to determine which dry needling technique produces greater improvements in muscle properties (ultrasound and EMG findings), pain intensity, and functional disability. Intervention: Participants will be randomly assigned to receive either deep DN or superficial DN. Each participant will undergo four treatment sessions over a two-week period. Assessments: Outcomes will be measured at three time points:
- Baseline (before treatment)
- Post-treatment (end of week 2)
- Follow-up (4 weeks after treatment)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedFirst Posted
Study publicly available on registry
June 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
June 9, 2026
June 1, 2026
1 year
September 17, 2025
June 4, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Upper Trapezius Muscle Thickness by B-mode Sonography
B-mode sonography will be used to measure the thickness at rest of the upper trapezius muscle by calculating the greatest distance between the lower and upper boundaries of the muscle, expressed in millimeters. The ultrasonic probe was positioned in alignment with the muscle fibers of the upper trapezius muscle. The MTrP should appear as a concentrated area with reduced echogenicity (darker) and an uneven echotexture (Taheri et al., 2016; Adigozali et al., 2017). B-mode sonography is highly reliable in assessing muscle thickness (ICC = 0.98) (Adigozali et al., 2016).
Baseline, Post two weeks and post 4 weeks
Upper Trapezius Muscle Stiffness by Strain Elastography
Strain elastography will be used to measure tissue stiffness. Images will be obtained with the linear transducer positioned longitudinally along the muscle fibers, while applying gentle, rhythmic compression to ensure adequate tissue deformation. Care will be taken to maintain consistent pressure and probe alignment throughout the examination. Regions of interest (ROIs) will be selected within the upper trapezius muscle with a size of 5 mm2. The reference ROI will be positioned within the subcutaneous tissue, while a second ROI will be placed in the upper trapezius muscle fiber. Strain ratio will be measured (Sawada et al., 2020). In this imaging setup, softer tissues is displayed in red, whereas stiffer tissues is represented in blue. Strain elastography has demonstrated moderate to good reliability (ICC = 0.70-0.81) (Salavati et al., 2017)
Baseline, Post two weeks and post 4 weeks
Blood Flow by Doppler ultrasonography
Doppler ultrasonography will be used to visualize blood vessels and measure the speed of blood flow at both active MTrPs and muscle throughout both the systolic and diastolic periods. The sonographer will use the ultrasound transducer to apply two distinct levels of pressure to the muscle fibers of the upper trapezius muscle. The first level involves minimum pressure, with the transducer barely making contact with the skin surface. The second level provides moderate pressure and visible squeezing of the muscle. The peak systolic velocity (PSV; cm/s), end diastolic velocity (EDV; cm/s), and resistance index (RI) (Adigozali et al., 2017) will be calculated. The reliability of doppler ultrasonography in measuring blood flow is moderate to excellent (ICC = 0.67-0.87) (Adigozali et al., 2017; Sikdar et al., 2010).
Baseline, Post two weeks and post 4 weeks
Upper Trapezius Muscle Activity and Fatigability by Surface Electromyography
In this study, muscle activity of the affected upper trapezius was assessed using a Delsys Trigno™ wireless surface electromyography (sEMG) system (Delsys Inc., Natick, MA, USA). All measurements were performed by a well-trained physiotherapist. Skin preparation and sensor placement followed the Surface ElectroMyoGraphy for the Non-Invasive Assessment of Muscles (SENIAM recommendations, adapted for wireless integrated EMG sensors (Hermens et al., 2000). A single Trigno sensor was positioned over the upper trapezius muscle at approximately 50% of the distance between the spinous process of the seventh cervical vertebra (C7) and the acromion. The sensor was oriented with its long axis aligned parallel to the direction of the muscle fibers. Prior to sensor fixation using adhesive tape, the skin was prepared by shaving (if necessary), light abrasion, and cleaning with an alcohol swab to reduce skin impedance. EMG signals were sampled at a frequency of 1,000 Hz with a band width of 20-450
Baseline, Post two weeks and post 4 weeks
Secondary Outcomes (2)
Pain Intensity
Baseline, post two weeks and post 4 weeks
Neck Disability
Baseline, post two weeks and post 4 weeks
Study Arms (2)
Group 1: Deep Dry Needling
EXPERIMENTAL22 Participants randomly assigned to this group will receive deep dry needling targeting the myofascial trigger points (MTrPs) of the upper trapezius muscle. The procedure will be performed by a licensed physiotherapist at Qatif Central Hospital. The needle will be inserted into the muscle to reach the MTrP and provoke a local twitch response.
Group 2: Superficial Dry Needling
ACTIVE COMPARATOR22 Participants randomly assigned to this group will receive superficial dry needling applied to the skin area overlying the identified MTrPs of the upper trapezius muscle. The same physiotherapist will perform all procedures in the same clinical setting. The needle will be inserted minimally without penetrating the muscle or eliciting a local twitch response.
Interventions
* Deep Dry needling is performed by a trained physiotherapist using a sterile solid filiform needle inserted deeply into the muscle tissue to directly reach the myofascial trigger point (MTrP) within the upper trapezius. The needle is advanced until a local twitch response is elicited, aiming to disrupt dysfunctional motor endplate activity, improve local circulation, and reduce pain and muscle tension. Participants will receive four treatment sessions over two weeks. * Superficial dry needling is performed by a trained physiotherapist using a sterile solid filiform needle inserted superficially into the skin overlying the identified MTrP in the upper trapezius, without penetrating the muscle or eliciting a local twitch response. The technique aims to modulate pain through stimulation of cutaneous Aδ fibers and spinal inhibitory pathways. Participants will receive four treatment sessions over two weeks.
Eligibility Criteria
You may qualify if:
- Patients with neck pain
- Has least one active myofascial trigger point in the upper trapezius muscle
You may not qualify if:
- whiplash injury
- Prior cervical surgery
- Cervical radiculopathy
- Fibromyalgia
- Using analgesic treatment (e.g., physiotherapy or medication) within the week preceding participation
- Psychiatric disorders
- Any contraindication to dry needling (e.g., needle phobia and/or anticoagulant use).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Qatif Central Hospital
Dammam, Eastern Province, 32654, Saudi Arabia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ali M Alshami, PhD
Professor, Imam Abdulrahman Bin Faisal University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Musculoskeletal Rehabilitation Specialist
Study Record Dates
First Submitted
September 17, 2025
First Posted
June 9, 2026
Study Start
October 1, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
June 9, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share